Lnterleukin-l β, interleukin-6, and tissue inhibitor of metalloproteinase-l in the synovial fluid of the temporomandibular joint with respect to cartilage destruction

Oral Diseases

Volumn 6, Issue 6, 2000, Pages 383-390

  Shinoda, C ^a   Takaku, S ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Biochemical analysis; Interleukin; Synovial fluid; Temporomandibular joint; Tissue inhibitor of metalloproteinase l

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ANALYSIS OF VARIANCE; ARTHRALGIA; ARTICLE; ARTICULAR CARTILAGE; CHRONIC DISEASE; COMPARATIVE STUDY; DISLOCATION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; JOINT CHARACTERISTICS AND FUNCTIONS; MALE; METABOLISM; MYOFASCIAL PAIN; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; OSTEOLYSIS; PATHOLOGY; RADIOGRAPHY; STATISTICS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; ANALYSIS OF VARIANCE; ARTHRALGIA; BONE RESORPTION; CARTILAGE, ARTICULAR; CHRONIC DISEASE; DISLOCATIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-1; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MALE; OSTEOARTHRITIS; PROTEASE INHIBITORS; RANGE OF MOTION, ARTICULAR; STATISTICS; STATISTICS, NONPARAMETRIC; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISK; TEMPOROMANDIBULAR JOINT DISORDERS; TEMPOROMANDIBULAR JOINT DYSFUNCTION SYNDROME; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0034329259     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2000.tb00131.x     Document Type: Article

References (21)

1. Aghabeigi B, Haque M, Wasil M et al (1997). The role of oxygen free radicals in idiopathic facial pain. Br J Oral Maxillofac Surg 35: 161-165.
2. Alstergren P, Appelgren A, Appelgren B et al (1995). Determination of temporomandibular joint fluid concentrations using vitamin B12 as an internal standard. Eur J Oral Sci 103: 214-218.
3. Alstergren P, Emberg M, Kvarnstrom M et al (1998). Interleukin1β in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite. J Oral Maxillofac Surg 56: 1059-1066.
4. Balkwill FR, Burke F (1989). The cytokine network, Immunol Today 10: 299-302.
5. Bertazzolo N, Punzi L, Stefani MP et al (1994). Interrelationships between interleukin (IL)-l, IL-6 and IL-8 in synovial fluid of various arthropathies. Agents Actions 41: 90-92.
6. Cawston TE (1986). Proteinas inhibitors of metalo-proteinases. In: Barren AJ, Salvesen G, eds. Proteinase Inhibitors. Elsevier: Oxford, pp 589-610.
7. Falus A, Lakatos T, Smolen J (1992). Dissimilar biosynthesis of interleukin-6 by different areas of synovial membrance of patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 21: 116-119.
8. Fontana A, Hengartner H, Weber E et al (1982). Interleukin l activity in the synovial fluid of patients with rheumatoid arthritis. Rhematol Int 2: 49-53.
9. Fu K, Ma X, Zhang Z et al (1995). Tumor necrosis factor in synovial fluid of patients with temporomandibular disorders. J Oral Maxillofac Surg 53: 424-426.
10. Goto M, Sasao M, Yamanaka H et al (1987). Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 80: 786-796.
11. Hayakawa T, Yamashita K, Tanzawa K et al (1992). Growthpromoting activity of tissue inhibitor of metalloproteinases-l (TIMP-1) for a wide range of cells. FEBS Lett 298; 29-32.
12. Hirota W (1998). Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4,6-keto-prostaglandin F1α, prostaglandin F2α, and interleukin-1β in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 36: 35-38.
13. Hogquist KA, Unanue ER, Chaplin DD (1991). Release of IL-1 from mononuclear phagocytes. J Immunol 147: 2181-2186.
14. Hopkins SI, Humphreys M, Jayson MIV (1988). Cytokines in synovial fluid I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 72: 422-127.
15. Ishiguro N, Ito T, Iwata H el al (1996). Determination of stromlaisin-1 (MMP-3), 72 kDa and 92 kDa type 4 collagenase (MMP-2, 9), tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 23: 1599-1604.
16. Kaiyuan F, Xuchen M, Zhenkang Z et al (1993). Interleukin-1 activity in synovial fluids of temporomandibular joint disturbance syndrome. J Beijing Med Univ 25: 403-405.
17. Kaiyuan F, Xuchen M, Zhenkang Z et al (1995). Interleukin-6 in synovial fluid and HLA-DR expression in synovium from patients with temporomandibular disorders. J Orofac Pain 9: 131-137.
18. Kodama S, Iwata K, Iwata H et al (1990). Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 127: 103-108.
19. Kopp S (1998). The influence of neuropeptides, serotonin, and interleukin 1beta on temporomandibular joint pain and inflammation. J Oral Maxillofac Surg 56: 189-191.
20. Kubota E, Imamura H, Kubota T et al (1997). Interleukin 1β and stromelysin (MMP3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandibular joint. J Oral Maxillofac Surg 55: 20-27.
21. Kubota E, Kubota T, Matsumoto J et al (1998). Synovial fluid cytokines and proteinases as markers of temporomandibular joint disease. J Oral Maxillofac Surg 56: 192-198.